Same as Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) I don’t think dual listing with ADRs really worked there either. Seems to be such a painful way to go for small biotechs with not much benefit.
Ann: Imugene completes $35M Placement & Launches c.$30M SPP, page-367
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
-0.001(2.22%) |
Mkt cap ! $338.4M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.4¢ | $325.8K | 7.248M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 4549172 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 1415982 | 13 |
View Market Depth
| Last trade - 12.17pm 07/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |